CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-21 | Castle Jeremy Chief Operating Officer | Returned to the company | −5,636 | $2.68 | $15K | 247,031 |
| 2025-03-31 | Castle Jeremy Chief Operating Officer | Grant or award | +162,281 | 252,667 | ||
| 2025-03-26 | Castle Jeremy Chief Operating Officer | Purchase | +9,056 | $1.04 | $9K | 90,386 |
| 2025-03-26 | Castle Jeremy Chief Operating Officer | Purchase · Common Warrant | +4,528 | $0.13 | $566 | 4,528 |
| 2024-12-03 | Castle Jeremy Chief Operating Officer | Returned to the company | −1,130 | $0.16 | $181 | 81,330 |
| 2024-05-21 | Castle Jeremy Chief Operating Officer | Grant or award | +70,120 | 82,460 | ||
| 2024-05-21 | Castle Jeremy Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +175,299 | 175,299 | ||
| 2023-11-30 | Castle Jeremy Chief Operating Officer | Grant or award | +12,340 | 12,340 | ||
| 2023-11-30 | Castle Jeremy Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +30,849 | 30,849 |
Page 1 of 1 · 9 trades